Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors. - Wikidata - awgldk - TriplyDB

Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors.

Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors.

http://www.wikidata.org/entity/Q37249229

about

Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor.Bone mineral density screening among women with a history of breast cancer treated with aromatase inhibitors.Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer Assessment of bone health in breast cancer patients starting adjuvant aromatase inhibitors: A quality improvement clinical audit Bone health care for patients with prostate cancer receiving androgen deprivation therapy.Bone health management of Australian breast cancer survivors receiving hormonal therapy.Evaluation and management of skeletal disease in cancer care.Assessing information needs on bone health in cancer survivors.

P2860

Q35095538-9EEAE783-F740-4486-8161-D70C8D959E67 Q36613577-4D4BA2BA-5678-4643-9475-EB3243ABD065 Q37356084-B37FF156-250E-4304-9F17-2FD850402772 Q37499975-80D8F011-12BC-412D-A14F-2D4362BAEB71 Q38207463-8D048811-D575-4787-A626-F039B1E34A60 Q41391048-2911BE5E-7DA4-4D4B-ACFA-29D27EB471F6 Q50070694-9F6A7FCD-D639-4421-AF95-3EEA6FBF66A8 Q50553402-8FB890DD-7635-4ABB-9F1D-0686BB510186

P2860

Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors.

http://www.wikidata.org/entity/Q37249229

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Screening and management of os ...... ients on aromatase inhibitors.

@en

Screening and management of os ...... ients on aromatase inhibitors.

@nl

type

label

Screening and management of os ...... ients on aromatase inhibitors.

@en

Screening and management of os ...... ients on aromatase inhibitors.

@nl

prefLabel

Screening and management of os ...... ients on aromatase inhibitors.

@en

Screening and management of os ...... ients on aromatase inhibitors.

@nl

P1433

Q37249229-153FB208-837E-4E1B-89B1-DB676C237F6A

P1476

Q37249229-CE516BD0-E5FB-4152-85F6-B1033E85B6C7

P2093

Q37249229-14AC89BE-A312-4268-909A-FEAD6E7913D7

Q37249229-CFFDD6EC-6694-414E-894F-61DF3DD9A682

P2860

Q37249229-08C9471E-CD81-4BDB-A17B-99FD43C1A53B

Q37249229-4DED266C-E921-4F71-B077-6E2CAEA9327A

Q37249229-5422B482-708B-408D-8148-79DD65DAEDDA

Q37249229-5BF4899D-75A3-43E5-BDB9-3C1D5DDF231F

Q37249229-898165A3-31CC-4383-9C9D-660756A497FC

Q37249229-E34CD66B-66F9-4904-87C9-F11AD1B7B9AB

P304

Q37249229-DE86EA79-C62A-46A0-BEFD-31455076D3C0

P31

Q37249229-D784D573-269F-47F2-A65C-31D8B7F4239E

P356

Q37249229-FF800EA5-1FE3-4C2F-94CD-4D1CD662DB11

P433

Q37249229-8845FB05-79CB-4E90-8F5E-06823645EF24

P478

Q37249229-4587AACE-D050-4901-ADFA-29BEE49A4325

P577

Q37249229-B078B45A-7CD9-4AFB-BE29-56A5A42C5E62

P698

Q37249229-7185FDAD-4581-460B-BD47-86A7A5EA086C

P921

Q37249229-B8E5AC1E-8266-4705-B0D9-50774F8AB207

P356

1078155208091866

P1433

Journal of Oncology Pharmacy Practice

P1476

Screening and management of os ...... ients on aromatase inhibitors.

@en

P2093

Cindy L O'Bryant

http://www.w3.org/2001/XMLSchema#string

Kelli Gibson

http://www.w3.org/2001/XMLSchema#string

P2860

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study.

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer.

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

P304

139-145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1078155208091866

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18719068

http://www.w3.org/2001/XMLSchema#string

P921